Honglian Shi

School of Pharmacy - Pharmacology & Toxicology
Associate Professor
Director for Graduate Studies of Pharmacology and Toxicology
Primary office:
Malott Hall
Room 5044
University of Kansas
1251 Wescoe Hall Drive
Lawrence, KS 66045


I received a Ph.D. in biophysics with a specialization in oxidative stress research and have been conducting research in the field of oxidative stress since my graduation.

Research Interests

  • Oxidative stress in diseases
  • Redox regulations
  • Hypoxia/ischemia
  • Heavy metal toxicity
  • Antioxidant treatments

Selected Publications

Zhang, Z. Yan, J. & Shi, H. (2016). Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke. Neurobiology of disease, 95, 82-92. DOI:10.1016/j.nbd.2016.07.012

2nd among all schools of pharmacy in National Institutes of Health funding
Brings more than $20 million in external funding into the state each year
7 of 19 cancer drugs formulated through the National Cancer Institute were developed at the KU School of Pharmacy
3,000 free flu shots given to Kansans in need during the past 5 years
4,000 living alumni, 63 percent of them living and working in Kansas
KU pharmacists practice in 95 of Kansas’ 105 counties
20th among public schools of pharmacy.
—U.S. News & World Report
$20.2 million NIH research grant earned by Distinguished Professor Jeff Aubé was 2nd largest in Kansas history
100 percent placement after graduation for KU Pharm.D. students
Established in 1885 as the 1st professional program at KU